Status:
UNKNOWN
Home Testing of Blood Counts in Chemotherapy Patients
Lead Sponsor:
University of Leeds
Collaborating Sponsors:
Philips Healthcare
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators hypothesise that cancer patients on systemic anticancer therapy can measure a home blood count, temperature, record qualitative data and transfer the results electronically to the ho...
Eligibility Criteria
Inclusion
- Any solid tumour diagnosis being managed by either medical or clinical oncologists.
- Patients receiving one or more systemic chemotherapy drugs or targeted therapy at Leeds Cancer Centre.
- Adults ≥ 18 years.
- Live within boundaries of Local Care Direct service provision.
- Live in post-code with good 2G, 3G or GPRS connectivity according to coverage map.
Exclusion
- On hormone treatment only for their cancer.
- Participating in the active phase of a therapeutic clinical trial.
- Inability to give informed consent due to mental capacity or language barrier.
- Patient or carer unable or unlikely to be able to perform fine manipulation required to use lancet or cartridge to obtain capillary blood sample and result.
- Known inherited or acquired bleeding disorder.
- History of haematological malignancy.
- Known poorly controlled anti-coagulation (INR\>3.0 within 6 months)
- Prisoner in custody of HM Prison Service.
Key Trial Info
Start Date :
October 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2017
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT02234453
Start Date
October 1 2016
End Date
April 1 2017
Last Update
June 17 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St James's Teaching Hospital, Leeds Teaching Hospitals NHS Trust
Leeds, West Yorkshire, United Kingdom, LS9 7TF